Inhibiting angiotensin receptors in the brain: possible therapeutic implications : The expanding role of angiotensin receptor blockers in the management of the ederly hypertensiveUNGER, Thomas.Current medical research and opinion. 2003, Vol 19, Num 5, pp 449-451, issn 0300-7995, 3 p.Article

The ongoing Telmisartan alone and in combination with ramipril global endpoint trial programUNGER, Thomas.The American journal of cardiology. 2003, Vol 91, Num 10A, pp 28G-34G, issn 0002-9149Article

Drug interactions with angiotensin receptor blockers: A comparison with other antihypertensivesUNGER, Thomas; KASCHINA, Elena.Drug safety. 2003, Vol 26, Num 10, pp 707-720, issn 0114-5916, 14 p.Article

Quadratic Forms and Space-Time Block Codes From Generalized Quaternion and Biquaternion AlgebrasUNGER, Thomas; MARKIN, Nadya.IEEE transactions on information theory. 2011, Vol 57, Num 9, pp 6148-6156, issn 0018-9448, 9 p.Article

Vasoactive peptides, their receptors and drug developmentKUSSEROW, Heike; UNGER, Thomas.Basic & clinical pharmacology & toxicology (Print). 2004, Vol 94, Num 1, pp 5-12, issn 1742-7835, 8 p.Article

Angiotensin and its AT₂ receptor : new insights into an old systemSTOLL, Monika; UNGER, Thomas.Regulatory peptides. 2001, Vol 99, Num 2-3, pp 175-182, issn 0167-0115Article

Pharmacology of AT₁-receptor blockersUNGER, Thomas.Blood pressure. 2001, Vol 10, pp 5-10, issn 0803-7051, SUP3Conference Paper

Impacts of a common green certificate market on electricity and CO₂-emission markets in the Nordic countriesUNGER, Thomas; AHLGREN, Erik O.Energy policy. 2005, Vol 33, Num 16, pp 2152-2163, issn 0301-4215, 12 p.Article

Angiotensin AT1/AT2 receptors: Regulation, signalling and functionKASCHINA, Elena; UNGER, Thomas.Blood pressure. 2003, Vol 12, Num 2, pp 70-88, issn 0803-7051, 19 p.Article

A Symposium: Managing Cardiovascular and Cerebrovascular Risk: Recent Data and the Promise of the ONTARGET Trial ProgrammeSLEIGHT, Peter; UNGER, Thomas.The American journal of cardiology. 2003, Vol 91, Num 10A, issn 0002-9149, 36 p.Serial Issue

Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approachesUNGER, Thomas; PAULIS, Ludovit; SICA, Domenic A et al.European heart journal. 2011, Vol 32, Num 22, pp 2739-2747, issn 0195-668X, 9 p.Article

The rationale for choosing telmisartan and ramipril in the ONTARGET programmeUNGER, Thomas.European heart journal supplements. 2009, Vol 11, Num F, issn 1520-765X, F3-F8Conference Paper

Acidic pH and capsaicin activate mechanosensitive group IV muscle receptors in the ratHOHEISEL, Ulrich; REINÖHL, Jochen; UNGER, Thomas et al.Pain (Amsterdam). 2004, Vol 110, Num 1-2, pp 149-157, issn 0304-3959, 9 p.Article

Trials on blood pressore-lowering and secondary stroke preventionCHALMERS, John.The American journal of cardiology. 2003, Vol 91, Num 10A, pp 3G-8G, issn 0002-9149Article

Excitatory and modulatory effects of inflammatory cytokines and neurotrophins on mechanosensitive group IV muscle afferents in the ratHOHEISEL, Ulrich; UNGER, Thomas; MENSES, Siegfried et al.Pain (Amsterdam). 2005, Vol 114, Num 1-2, pp 168-176, issn 0304-3959, 9 p.Article

Physiology of aldosterone and pharmacology of aldosterone blockersSTRUTHERS, Allan D; UNGER, Thomas.European heart journal supplements. 2011, Vol 13, Num B, issn 1520-765X, B27-B30Article

The possible role of the NO-cGMP pathway in nociception: Different spinal and supraspinal action of enzyme blockers on rat dorsal horn neuronesHOHEISEL, Ulrich; UNGER, Thomas; MENSE, Siegfried et al.Pain (Amsterdam). 2005, Vol 117, Num 3, pp 358-367, issn 0304-3959, 10 p.Article

How cost-effective are new preventive strategies for cardiovascular disease?PROBSTFIELD, Jeffrey L.The American journal of cardiology. 2003, Vol 91, Num 10A, pp 22G-27G, issn 0002-9149Article

Heart rate and blood pressure interactions in the development of erectile dysfunction in high-risk cardiovascular patientsKRATZ, Mario T; SCHUMACHER, Helmut; SLEIGHT, Peter et al.European journal of preventive cardiology (Print). 2014, Vol 21, Num 3, pp 272-280, issn 2047-4873, 9 p.Article

Endothelial Dysfunction Plays a Key Role in Increasing Cardiovascular Risk in Type 2 Diabetes: The Hoorn StudyVAN SLOTEN, Thomas T; HENRY, Ronald M. A; DEKKER, Jacqueline M et al.Hypertension (Dallas, Tex. 1979). 2014, Vol 64, Num 6, pp 1299-1305, issn 0194-911X, 7 p.Article

New Polymer Matrix System for Phosphorescent Organic Light-Emitting Diodes and the Role of the Small Molecular Co-hostSALERT, Beatrice Ch. D; KRUEGER, Hartmut; BAGNICH, Sergey A et al.Journal of polymer science. Part A. Polymer chemistry. 2013, Vol 51, Num 3, pp 601-613, issn 0887-624X, 13 p.Article

Characterization of new PPARγ agonists: Benzimidazole derivatives—importance of positions 5 and 6, and computational studies on the binding modeGOEBEL, Matthias; WOLBER, Gerhard; MARKT, Patrick et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 16, pp 5885-5895, issn 0968-0896, 11 p.Article

The angiotensin AT2 receptor in left ventricular hypertrophyMUSCHA STECKELINGS, U; WIDDOP, Robert E; PAULIS, Ludovit et al.Journal of hypertension. 2010, Vol 28, issn 0263-6352, S50-S55, SUP1Article

Comparison between single and combined treatment with candesartan and pioglitazone following transient focal ischemia in rat brainSCHMERBACH, Kristin; SCHEFE, Jan H; KRIKOV, Maxim et al.Brain research. 2008, Vol 1208, pp 225-233, issn 0006-8993, 9 p.Article

Angiotensin II type 1: Receptor activating antibodies in renal-allograft rejectionDRAGUN, Duska; MÜLLER, Dominik N; MAZAK, Istvan et al.The New England journal of medicine. 2005, Vol 352, Num 6, pp 558-569, issn 0028-4793, 12 p.Article